Back

HbA1C and Fructosamine levels during Infancy

Schneider Aguirre, R.; Al-Raddadi, A.; DiMeglio, L. A.; Eugster, E. A.

2025-05-08 endocrinology
10.1101/2025.05.07.25327198 medRxiv
Show abstract

Due to a high percentage of hemoglobin F, Hemoglobin A1C (HbA1C) measurements are inaccurate for assessing glycemia in infants. We aimed to determine when HbA1C might have utility and to assess the value of fructosamine. We measured HbA1C in healthy infants aged 3 weeks to 12 months. Hemoglobin, HbA1C, hemoglobin electrophoresis, fructosamine, and albumin levels were collected. Mean age was 193.9 {+/-} 94.5 days; participants were 60.9% male, 80.4% white, and 15.2% Hispanic. Mean HbA1C (n=31) and fructosamine (n=33) were 5.0% (31 mmol/mol) (range 4.4-5.9%; 25-41 mmol/mol) and 217 (range 186-261 mCmol/L), respectively. HbA1C percentages negatively correlated with HbF percentages (p < 0.005) and rose with increasing age in infants <6 months (p < 0.01). Fructosamine did not vary with age. Normalizing HbA1C to hemoglobin fractions or fructosamine to albumin did not change significance. We conclude that HbA1C values (via HPLC) likely become a reliable marker of glycemia after 6 months of age and that fructosamine may be a better measure during this young age.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.